Skip to main content
. Author manuscript; available in PMC: 2014 Nov 21.
Published in final edited form as: Anticancer Agents Med Chem. 2012 Dec;12(10):1221–1238. doi: 10.2174/187152012803833080

Figure 2.

Figure 2

Increase in IL-6 is associated with increase in biomarkers of inflammation severity and cancer progression. An increase in IL-6 signaling is associated with poor prognosis.